Neurocrine Bioscienc (NBIX-Q) Analyst Research & Price Targets - The Globe and Mail

Add to Watchlist Create Alerts

Real-Time Last Update

Last Sale Cboe BZX Real-Time

Volume

Current Target Price

High Target Price

Mean Target Price

Low Target Price

Median Target Price

Earnings Estimates

	Current Qtr06/2024	Next Qtr09/2024	Fiscal Yr12/2024	Fiscal Yr12/2025
Average Estimate	1.04	1.29	4.17	6.51
Number of Estimates	11	9	10	11
High Estimate	1.62	1.51	5.51	8.52
Low Estimate	0.27	1.15	3.10	4.81
Prior Year	0.95	0.82	2.47	4.17
Growth Rate Est. (year over year)	+9.47%	+57.32%	+68.83%	+56.12%

Earnings History - Surprises*

	Qtr Ending03/2024	Qtr Ending12/2023	Qtr Ending09/2023	Qtr Ending06/2023
Reported	$0.42	$1.44	$0.82	$0.95
Estimate	$1.04	$1.13	$0.91	$0.77
Difference	-0.62	+0.31	-0.09	+0.18
Surprise	-59.62%	+27.43%	-9.89%	+23.38%

* Earnings are based on GAAP income from continuing operations.

Average Analyst Ratings

4.50

3 Mths Ago26

4.50

2 Mths Ago26

4.48

1 Mth Ago25

4.52

Current27

Ratings Values:

Strong Buy5

Moderate Buy4

Hold3

Moderate Sell2

Strong Sell1

Ratings Breakdown

	3 Mths Ago	2 Mths Ago	1 Mth Ago	Current
# of Analysts:	26	26	25	27
	19 1	19 1	18 1	20 1
Holds	6	6	6	6

Key:

Strong Buy

Moderate Buy

Hold

Moderate Sell

Strong Sell

More from The Globe

Dividend investing has lost its mojo. Here’s why – and how to adapt

The Globe Investing Club 2024: Let the competition begin!

Here’s the real reason your Canadian stocks can’t keep up

Dow ends above 40,000 milestone, TSX also at fresh record high

number cruncher

U.S technology stocks with earnings and price momentum

Lightspeed Commerce stock soars on better-than-expected profit forecast

GameStop, AMC dive further as meme stocks rally tapers off

The close: Dow briefly hits 40,000 milestone, TSX rises on upbeat earnings